Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer

Published:2023-07-20 Issue:15 Volume:66 Page:10734-10745
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Cárdenas Emilio L.¹,O’Rourke Rachel L.¹,Menon Arya¹,Meagher Jennifer²,Stuckey Jeanne²³,Garner Amanda L.¹^ORCID

Affiliation:

1. Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States

2. Life Science Institute, University of Michigan, Ann Arbor, Michigan 48109, United States

3. Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States

Funder

National Cancer Institute

Michigan Technology Tri-Corridor

Rogel Cancer Center, University of Michigan

Michigan Economic Development Corporation

National Institute of General Medical Sciences

Argonne National Laboratory

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00917

Reference47 articles.

1. Targeting the translation machinery in cancer

2. Translational Control in Cancer

3. The plasticity of mRNA translation during cancer progression and therapy resistance

4. Oncogenic Ras and Akt Signaling Contribute to Glioblastoma Formation by Differential Recruitment of Existing mRNAs to Polysomes

5. The MYC oncogene — the grand orchestrator of cancer growth and immune evasion

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP